Back to Agendas
[V4-S1] Use of Human Organ/Tissue for New Drug Development
Session Chair(s)
Satoshi Toyoshima, PhD
Professor, Faculty of Pharmacy, Graduate School of Pharmaceutical Sciences, Musashino University, Japan
It is essential to utilize human organ/tissue (biomaterial) for new drug development. Unnecessary organ/tissue in case of human organ transplantation is effectively utilized in the US/EU. However Japanese scientific society tends to hesitate to utilize unnecessary human organ/ tissue for drug development because Japanese feel it is morally at fault. The first speaker will provide a summary of the background, including the current situation and problems. The second speaker will provide his opinion from the legal and the ethical viewpoint. Then, two speakers from academia and a pharmaceutical company will discuss the matter from their standpoints.
Speaker(s)
Katashi Fukao, MD, PhD
President, HAB Research Organization, Japan
Usage of Human Organs, Tissues and Cells for Research in Japan -Past Activities and Challenges For Future-
Saku Machino
Professor Emeritus, Sophia University, Japan
Use of Human Tissue for Medical Research: Its Ethical and Legal Basis
Ikuo Horii, PhD
DSRD Global Consultant, Pfizer Global Research & Development, Japan
Utilization of Human Cell/Tissue for Drug Discovery and Development: Expansion toward Precision Medicine
Hiroyuki Kusuhara, PhD
Professor, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Japan
Significance of human tissues in drug development: prediction of pharmacokinetics of investigational drugs in humans
Have an account?